Search Results - "Surböck, B."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
  2. 2

    P07.10.A CLINICAL OUTCOMES OF SPOT-SCANNING PROTON BEAM THERAPY FOR IDH-MUTANT CNS WHO GRADE 2 AND 3 GLIOMA by Pelak, M J, Lütgendorf-Caucig, C, Flechl, B, Mock, U, Mozes, P, Fossati, P, Georg, P, Fussl, C, Surböck, B, Mumot, M, Stock, M, Wolfsberger, S, Urbanic Purkart, T, Calabek-Wohinz, B, Hug, E

    Published in Neuro-oncology (Charlottesville, Va.) (08-09-2023)
    “…Abstract BACKGROUND The latest WHO brain tumour classification puts utmost emphasis on prognostic significance of isocitrate dehydrogenase (IDH) mutation…”
    Get full text
    Journal Article
  3. 3
  4. 4

    P02.01 ABTR-SANO Real-World Pattern of Care Study on Glioblastoma in the Austrian Population by Oberndorfer, S., Marosi, C., Payer, F., Nowosielski, M., Floria, C., Hager, A., Stultschnig, M., Surböck, B., Pichler, J., Wöhrer, A.

    Published in Neuro-oncology (Charlottesville, Va.) (01-10-2016)
    “…Glioblastoma is the most common malignant brain tumor in adults. Since 2005, state-of-the-art treatment consists of maximal safe resection followed by combined…”
    Get full text
    Journal Article